- Home
- SIF vs COEP Comparison
SIF vs COEP Comparison
Compare SIF & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- COEP
- Stock Information
- Founded
- SIF 1913
- COEP 2017
- Country
- SIF United States
- COEP United States
- Employees
- SIF N/A
- COEP N/A
- Industry
- SIF Office Equipment/Supplies/Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIF Industrials
- COEP Health Care
- Exchange
- SIF Nasdaq
- COEP Nasdaq
- Market Cap
- SIF 22.6M
- COEP 22.3M
- IPO Year
- SIF N/A
- COEP N/A
- Fundamental
- Price
- SIF $3.65
- COEP $10.28
- Analyst Decision
- SIF
- COEP
- Analyst Count
- SIF 0
- COEP 0
- Target Price
- SIF N/A
- COEP N/A
- AVG Volume (30 Days)
- SIF 11.7K
- COEP 1.0M
- Earning Date
- SIF 02-12-2025
- COEP 11-13-2024
- Dividend Yield
- SIF N/A
- COEP N/A
- EPS Growth
- SIF N/A
- COEP N/A
- EPS
- SIF N/A
- COEP N/A
- Revenue
- SIF $79,633,000.00
- COEP N/A
- Revenue This Year
- SIF N/A
- COEP N/A
- Revenue Next Year
- SIF N/A
- COEP N/A
- P/E Ratio
- SIF N/A
- COEP N/A
- Revenue Growth
- SIF 20.53
- COEP N/A
- 52 Week Low
- SIF $2.90
- COEP $2.31
- 52 Week High
- SIF $5.96
- COEP $13.58
- Technical
- Relative Strength Index (RSI)
- SIF 44.14
- COEP 78.56
- Support Level
- SIF $3.48
- COEP $6.22
- Resistance Level
- SIF $3.80
- COEP $10.00
- Average True Range (ATR)
- SIF 0.13
- COEP 1.75
- MACD
- SIF 0.00
- COEP 0.36
- Stochastic Oscillator
- SIF 14.80
- COEP 100.00
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.